Depression: < 50% reduction in scale scores at end of treatment (primary outcome) · people with depression after stroke
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes depression: < 50% reduction in scale scores at end of treatment… compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
1 finding from 1 review
Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke
1 finding from 1 review
Adverse events: death ‐ at end of treatment (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: death (secondary outcome) compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
1 finding from 1 review
Adverse events: all ‐ central nervous system events (e.g. headache, seizures) (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: all ‐ central nervous system events (e.g. headache,… compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
1 finding from 1 review
Adverse events: all ‐ other events ‐ not listed above (e.g. dysuria, neck pain, eye discomfort) (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: all ‐ other events ‐ not listed above (e.g.… compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
1 finding from 1 review
Live birth · obese women with subfertility
It is very uncertain whether pharmacological intervention changes live birth compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Ongoing pregnancy · obese women with subfertility
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Miscarriage · obese women with subfertility
It is very uncertain whether pharmacological intervention changes miscarriage compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Adverse events (GI) · obese women with subfertility
It is very uncertain whether pharmacological intervention changes adverse events (GI) compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Clinical pregnancy · obese women with subfertility
It is very uncertain whether pharmacological intervention changes clinical pregnancy compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Weight changeBMI WHR · obese women with subfertility
1 finding from 1 review
Quality of life/Mental health outcome · obese women with subfertility
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Effect on later sexual function · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
1 finding from 1 review
Sexual satisfaction · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: quality of life · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Psychological well‐being (secondary outcome) Not addressed · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Marital/relationship/partner satisfaction (secondary outcome) · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
1 finding from 1 review
Secondary outcome: all adverse events · men (aged between 23 and 45) with premature ejaculation within 3 months after stroke
1 finding from 1 review
Live birth · obese women with subfertility
Non‐pharmacological intervention showed no clear difference in live birth compared with no intervention or placebo (low certainty).
1 finding from 1 review
Ongoing pregnancy · obese women with subfertility
Non‐pharmacological intervention showed no clear difference in ongoing pregnancy compared with no intervention or placebo (low certainty).
1 finding from 1 review